EPISODE · Feb 20, 2025 · 30 MIN
Your Voice Matters—Let’s Talk Menopause
from Dr. Brendan McCarthy · host Dr. Brendan McCarthy
Welcome to the podcast with Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center in Tempe, Arizona. Your feedback and comments shape the discussions we have here—because your voice matters. In this episode, Dr. McCarthy addresses some of the most common questions and misconceptions about menopause and hormone replacement therapy (HRT). He breaks down the science, clears up misunderstandings, and emphasizes the importance of personalized care—whether you choose HRT or not. This episode is part of an ongoing series on menopause treatment, driven by the real concerns and questions from listeners like you. Dr. McCarthy explains the role of estrogen in health, the impact of stopping hormone therapy, and alternative approaches to managing symptoms like bone loss, cholesterol changes, and mood fluctuations. Dr. Brendan McCarthy founded Protea Medical Center in 2002. While he’s been the chief medical officer, Protea has grown and evolved into a dynamic medical center serving the Valley and Central Arizona. A nationally recognized as an expert in hormone replacement therapy, Dr McCarthy s the only instructor in the nation who teaches BioHRT on live patients. Physicians travel to Arizona to take his course and integrate it into their own practices. Besides hormone replacement therapy, Dr. McCarthy has spoken nationally and locally before physicians on topics such as weight loss, infertility, nutritional therapy and more. Thank you for tuning in and don't forget to hit that SUBSCRIBE button! Let us know in the COMMENTS if you have any questions or what you may want Dr. McCarthy to talk about next! Check out Dr. Brendan McCarthy's Book! https://www.amazon.com/Jump-Off-Mood-Swing-Hormones/dp/0999649604 --More Links-- Instagram: www.instagram.com/drbrendanmccarthy TikTok: www.tiktok.com/drbrendanmccarthy Clinic Website: www.protealife.com
What this episode covers
Welcome to the podcast with Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center in Tempe, Arizona. Your feedback and comments shape the discussions we have here—because your voice matters. In this episode, Dr. McCarthy addresses some of the most common questions and misconceptions about menopause and hormone replacement therapy (HRT). He breaks down the science, clears up misunderstandings, and emphasizes the importance of personalized care—whether you choose HRT or not. This episode is part of an ongoing series on menopause treatment, driven by the real concerns and questions from listeners like you. Dr. McCarthy explains the role of estrogen in health, the impact of stopping hormone therapy, and alternative approaches to managing symptoms like bone loss, cholesterol changes, and mood fluctuations. Dr. Brendan McCarthy founded Protea Medical Center in 2002. While he’s been the chief medical officer, Protea has grown and evolved into a dynamic medical center serving the Valley and Central Arizona. A nationally recognized as an expert in hormone replacement therapy, Dr McCarthy s the only instructor in the nation who teaches BioHRT on live patients. Physicians travel to Arizona to take his course and integrate it into their own practices. Besides hormone replacement therapy, Dr. McCarthy has spoken nationally and locally before physicians on topics such as weight loss, infertility, nutritional therapy and more. Thank you for tuning in and don't forget to hit that SUBSCRIBE button! Let us know in the COMMENTS if you have any questions or what you may want Dr. McCarthy to talk about next! Check out Dr. Brendan McCarthy's Book! https://www.amazon.com/Jump-Off-Mood-Swing-Hormones/dp/0999649604 --More Links-- Instagram: www.instagram.com/drbrendanmccarthy TikTok: www.tiktok.com/drbrendanmccarthy Clinic Website: www.protealife.com
NOW PLAYING
Your Voice Matters—Let’s Talk Menopause
No transcript for this episode yet
Similar Episodes
Jul 14, 2026 ·65m
Jul 7, 2026 ·54m
Jun 30, 2026 ·98m
Jun 23, 2026 ·35m
Jun 16, 2026 ·100m
Jun 9, 2026 ·83m